PDL BioPharma, Inc. (PDLI) Tops Q2 EPS by 4c
Tweet Send to a FriendGet Alerts PDLI Hot Sheet
Price: $8.37 +0.24%
Revenue Growth %: -7.0%
Financial Fact:
Total revenues: 91.85M
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: -7.0%
Financial Fact:
Total revenues: 91.85M
Today's EPS Names:
ANF, DXLG, FL, More
Trade PDLI Now!
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q2 EPS of $0.53, $0.04 better than the analyst estimate of $0.49. Revenue for the quarter came in at $125.9 million versus the consensus estimate of $125.14 million.
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Pandora (P) Pops Higher on Q1 Results; Expands Listener Base by 2.5M Subs
- Taomee Holdings Ltd. (TAOM) Misses Q1 EPS by 2c; Guides Q2 Sales
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
